Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 18 EP applications Stephen John Eves Evans has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11717011

IMMUNOGENIC PROTEINS AND COMPOSITIONS

IPC classification:
A61K 39/09, C07K 14/315
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11188902

Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use

IPC classification:
C12N 1/20, C12P 21/02
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP11758029

BACTERICIDAL ANTIBODY ASSAYS TO ASSESS IMMUNOGENICITY AND POTENCY OF MENINGOCOCCAL CAPSULAR SACCHARIDE VACCINES

IPC classification:
A61K 39/095, G01N 33/569
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline S.A.
Status:
EXAMINATION IN PROGRESS
EP12709382

COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT

IPC classification:
A61K 31/4375, A61K 31/66, A61K 33/06, A61K 33/08, A61K 33/42, A61K 39/00, A61K 39/095, A61K 39/13, A61K 39/295, A61K 39/39
Applicant:
Novartis AG
Agent:
Carpmaels & Ransford LLP
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12781365

FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE

IPC classification:
A61K 39/05
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13705791

PILUS PROTEINS AND COMPOSITIONS

IPC classification:
C07K 1/00
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15151845

Fermentation processes for cultivating streptococci and purification processes for obtaining CPS therefrom

IPC classification:
A61K 39/00, C12N 1/20, C12P 19/04, C12Q 3/00
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13766496

OUTER MEMBRANE VESICLES

IPC classification:
A61K 39/00
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13802107

CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

IPC classification:
A61K 39/08, A61K 39/40, A61P 31/04, C07K 14/33, C07K 16/12, C12N 15/31
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13792601

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/09
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13795176

IMMUNOGENIC COMPOSITIONS

IPC classification:
A61K 39/00, A61K 39/02, A61K 39/05, A61K 39/08, A61K 39/09, A61K 39/13
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP14167449

Polysaccharides produced by CPSC mutants

IPC classification:
A61K 39/09, C07K 14/315, C08B 37/00, C12P 19/04
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION REFUSED
EP15193267

HYBRID POLYPEPTIDES INCLUDING MENINGOCOCCAL FHBP SEQUENCES

IPC classification:
A61K 39/095, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11764862

GENERIC ASSAYS FOR DETECTION OF MAMMALIAN REOVIRUS

IPC classification:
C12Q 1/70
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15707351

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

IPC classification:
A61K 39/095, C07K 14/095, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION REQUESTED
EP15720977

PURIFICATION OF SECRETED POLYSACCHARIDES FROM S. AGALACTIAE

IPC classification:
A61K 39/09, C07K 14/315, C08B 37/00, C12P 19/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15744610

CARRIER MOLECULE FOR ANTIGENS

IPC classification:
A61P 37/04, A61K 47/50
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION REQUESTED
EP15813399

PURIFICATION OF STREPTOCOCCAL CAPSULAR POLYSACCHARIDE

IPC classification:
A61K 39/09, C08B 37/00
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature